Page last updated: 2024-09-04

n-methylpiperidin-4-yl propionate and Central Nervous System Disease

n-methylpiperidin-4-yl propionate has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ficaro, EP; Kilbourn, MR; Koeppe, RA; Kuhl, DE; Raffel, DM; Snyder, SE1

Trials

1 trial(s) available for n-methylpiperidin-4-yl propionate and Central Nervous System Disease

ArticleYear
Dual-[11C]tracer single-acquisition positron emission tomography studies.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2001, Volume: 21, Issue:12

    Topics: Brain; Carbon Radioisotopes; Central Nervous System Diseases; Computer Simulation; Flumazenil; GABA Modulators; Humans; Models, Biological; Propionates; Tetrabenazine; Tomography, Emission-Computed

2001